|Videos|October 24, 2022
Medical Crossfire on the Paradigm Shifts in Migraine Therapy: Jessica Ailani, MD
Author(s)Jessica Ailani, MD
The director of the MedStar Georgetown University Hospital Headache Center tells her experience in a medical crossfire as the migraine cochair at the fourth annual International Congress on the Future of Neurology. [WATCH TIME: 5 minutes]
Advertisement
WATCH TIME: 5 minutes
“I will tell you that in headache medicine, I really struggled with telemedicine. I personally think there are a couple of benefits to it, but there are a lot of challenges that people don't talk about. The challenge of licensing in multiple states, [for example]. I think that many providers think you're just covered if you're licensed in 1 state and that's actually not true.”
Jessica Ailani, MD, director of the MedStar Georgetown University Hospital Headache Center, served as a cochair at the 2022 International Congress on the Future of Neurology (IFN) annual meeting, held September 23-24, in Manhattan, New York. She mentioned that one of the takeaways from the meeting was the discussion around telemedicine and other shifts in the paradigm of neurologic care.
As many of her patients are comorbid as well as taking newer treatment options, she tries to ensure her understanding of what they are taking and how those medicines could interact with one another. She also expressed her concern to educate herself on different treatments to improve the prognostic capabilities for each patient.
In a recent conversation with NeurologyLive®, Ailani shared her takeaways from participating in a medical crossfire event at the IFN annual meeting with Stewart Tepper, MD, professor of neurology, Geisel School of Medicine, Darthmouth, on the topic of “Best Practices and Paradigm Changes for Acute and Prophylactic Therapy.” She also offered reflections from the event, including how the future is looking different as the use of treatments are changing.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
September 15th 2025
- 2025 Women in Neurology Conference: Educating, Mentoring, and Networking
September 15th 2025
- This Week on NeurologyLive® — September 15, 2025
September 15th 2025
- NeurologyLive® Brain Games: September 14, 2025
September 14th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
2
Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
3
10 Years of the Women Neurologists Group: A Preview of the 4th Annual Conference
4
This Week on NeurologyLive® — September 15, 2025
5